MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 149 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,097,000 | -96.3% | 20,901 | -97.6% | 0.00% | -100.0% |
| Q2 2020 | $29,502,000 | +44.1% | 886,742 | +17.8% | 0.01% | +22.2% |
| Q1 2020 | $20,470,000 | +60.7% | 752,590 | +16.6% | 0.01% | +125.0% |
| Q4 2019 | $12,740,000 | +85.6% | 645,699 | +21.9% | 0.00% | +100.0% |
| Q3 2019 | $6,865,000 | -11.4% | 529,687 | -14.9% | 0.00% | 0.0% |
| Q2 2019 | $7,748,000 | -39.4% | 622,348 | -29.3% | 0.00% | -50.0% |
| Q1 2019 | $12,785,000 | +14.8% | 879,932 | -12.8% | 0.00% | 0.0% |
| Q4 2018 | $11,141,000 | -77.9% | 1,009,146 | -47.4% | 0.00% | -75.0% |
| Q3 2018 | $50,420,000 | +88.3% | 1,917,113 | +46.4% | 0.02% | +77.8% |
| Q2 2018 | $26,772,000 | +11.8% | 1,309,123 | -0.8% | 0.01% | 0.0% |
| Q1 2018 | $23,956,000 | -46.1% | 1,319,931 | -58.5% | 0.01% | -43.8% |
| Q4 2017 | $44,415,000 | -31.5% | 3,183,838 | -9.2% | 0.02% | -33.3% |
| Q3 2017 | $64,886,000 | +10.1% | 3,507,388 | +0.5% | 0.02% | +33.3% |
| Q2 2017 | $58,960,000 | +21.2% | 3,488,715 | -4.3% | 0.02% | +12.5% |
| Q1 2017 | $48,656,000 | -10.8% | 3,644,648 | +0.6% | 0.02% | -11.1% |
| Q4 2016 | $54,526,000 | +26.0% | 3,623,003 | -2.2% | 0.02% | +20.0% |
| Q3 2016 | $43,286,000 | +6.3% | 3,702,883 | -1.8% | 0.02% | 0.0% |
| Q2 2016 | $40,715,000 | +40.5% | 3,769,912 | +20.2% | 0.02% | +25.0% |
| Q1 2016 | $28,973,000 | -48.1% | 3,135,595 | -16.7% | 0.01% | -45.5% |
| Q4 2015 | $55,832,000 | +286.1% | 3,762,228 | +326.9% | 0.02% | +266.7% |
| Q3 2015 | $14,461,000 | -30.5% | 881,213 | -3.4% | 0.01% | -25.0% |
| Q2 2015 | $20,816,000 | +992.7% | 912,597 | +628.1% | 0.01% | +700.0% |
| Q1 2015 | $1,905,000 | +40.0% | 125,334 | +10.9% | 0.00% | 0.0% |
| Q4 2014 | $1,361,000 | +1.3% | 113,022 | -4.5% | 0.00% | 0.0% |
| Q3 2014 | $1,343,000 | -7.1% | 118,409 | -1.0% | 0.00% | 0.0% |
| Q2 2014 | $1,445,000 | -28.1% | 119,631 | -30.6% | 0.00% | 0.0% |
| Q1 2014 | $2,009,000 | -45.0% | 172,479 | -16.6% | 0.00% | 0.0% |
| Q4 2013 | $3,655,000 | +78.5% | 206,727 | +45.3% | 0.00% | 0.0% |
| Q3 2013 | $2,048,000 | +11.3% | 142,301 | +16.5% | 0.00% | 0.0% |
| Q2 2013 | $1,840,000 | – | 122,155 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |